CompletedPhase 3NCT05707832

A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive Aspergillus

Studying Aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
CSPC Ouyi Pharmaceutical Co., Ltd.
Principal Investigator
Sizhou Feng
Chinese Academy of Medical Sciences
Intervention
Amphotericin B cholesteryl Sulfate Complex for Injection(drug)
Enrollment
31 enrolled
Eligibility
18 years · All sexes
Timeline
20232025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05707832 on ClinicalTrials.gov

Other trials for Aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Aspergillosis

← Back to all trials